3M $6.7 billion acquisition of Acelity

Overview:

• 3M has acquired medical device company Acelity in a $6.7 billion deal. 
• Acelity was sold by a consortium that included Apax Partners, the Canada Pension Plan Investment Board and the Public Sector Pension Investment Board. 
• Credit Suisse acted as financial adviser for 3M while JP Morgan and Goldman Sachs advised the consortium. 
• The transaction is expected to close in the second half of 2019. 

Kurt Stumpo - US Editor